Genentech, Roche Near A Deal

The board of Genentech is near a deal to sell the biotech company for $95 a share to suitor Roche. The two sides are still negotiating final terms of the $46.7 billion deal.

Topics:  genentech   roche   deal   
BING NEWS:
  • Roche Executing Commercially, But R&D Productivity Remains A Work In Progress
    Roche's strategic changes in drug development and M&A activity may drive future growth, despite recent setbacks in clinical trials. Read more here.
    01/3/2025 - 7:56 pm | View Link
  • Roche projected to claim pharma's 2025 sales crown as Novo, Lilly climb rankings: Evaluate
    The story of Eli Lilly and Novo Nordisk’s GLP-1 dominance is likely to play out again in 2025 as the metabolic medicine rivals continue to smooth over supply issues and rake in dividends from their | ...
    01/3/2025 - 4:07 am | View Link
  • Fierce Pharma Asia—Roche, Innovent's ADC deal; Lessons from AZ's China probes; Viatris' warning letter
    In separate DLL3 antibody-drug conjugate (ADC) deals, Roche licensed from Innovent Biologics and Ideaya reached for Hengrui. | In separate DLL3 antibody-drug conjugate deals, Roche licensed from ...
    01/2/2025 - 11:37 pm | View Link
  • New year, new $1B deal: Roche taps Innovent for new DLL3 ADC drug
    Roche Holding AG kicked off the new year (again) with a potential $1 billion deal, including $80 million up front, for exclusive rights to Innovent Biologics Inc.’s IBI-3009, a DLL3-targeting antibody ...
    01/2/2025 - 9:26 am | View Link
  • Roche Kicks Off 2025 Committing a Potential $1B for Another ADC From China
    Roche has once again returned to China to bolster its antibody-drug conjugate pipeline, this time striking a licensing deal with Innovent for $1 billion in biobucks.
    01/2/2025 - 4:40 am | View Link
  • More
BING SEARCH:
  • About Us
    Genentech's South San Francisco campus serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech Research and Early Development continues to embrace the spirit of a “startup” and operates as a separate business unit within Roche.
    01/4/2025 - 1:15 am | View Website
  • Our Medicines & Products
    Genentech Access Solutions offers coverage support, patient assistance, other useful information.
    01/2/2025 - 9:05 pm | View Website
  • Medicines and Products
    Genentech has multiple medicines for serious and life-threatening medical conditions. Access information and resources on each of our medicines
    01/2/2025 - 3:04 am | View Website
  • Visit Us
    Following our March 2009 merger with Roche, Genentech's South San Francisco campus became the headquarters for Roche pharmaceutical operations in the United States. All of Genentech's U.S. sites are united by our goal of meeting the needs of patients.
    12/31/2024 - 2:24 am | View Website
  • Genentech: Statements | Genentech To Expand Next-Generation ...
    Genentech, a member of the Roche Group, today announced the construction of a new biologics manufacturing facility at its Oceanside, CA campus, marking the occasion with a groundbreaking ceremony.
    12/29/2024 - 4:24 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News